# Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas

> **NCT01438476** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 178 (actual)

## Conditions studied

- Liver Cancer
- Pancreatic Cancer

## Interventions

- **PROCEDURE:** Intravenous Patient-Controlled Analgesia (IVPCA)
- **PROCEDURE:** Thoracic Epidural Analgesia (TEA)
- **BEHAVIORAL:** Questionnaires
- **BEHAVIORAL:** Pain Assessment

## Key facts

- **NCT ID:** NCT01438476
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-26
- **Primary completion:** 2017-10-18
- **Final completion:** 2017-10-18
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2020-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01438476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01438476, "Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01438476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*